Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 948-957

  Robson, Nicole D ^a   Telesnitsky, Alice ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; VIRUS GENE; VIRUS REPLICATION;

EID: 0032902552     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.948-957.1999     Document Type: Article

References (55)

1. Bieth, E., and J.-L. Darlix. 1991. Complete nucleotide sequence of a highly infectious avian leukosis virus. Nucleic Acids Res. 20:367.
2. Bowman, E. H., V. K. Pathak, and W.-S. Hu. 1996. Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNAs. J. Virol. 70: 1687-1694.
3. Bowman, R. R., W.-S. Hu, and V. K. Pathak. 1998. Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J. Virol. 72:5198-5206.
4. Bray, M., S. Prasad, J. W. Dubay, E. Hunter, K.-T. Jeang, D. Rekosh, and M.-L. Hammarskjold. 1994. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 91: 1255-1260.
5. Bushman, F. D., and R. Craigie. 1990. Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro. J. Virol. 64:5645-5648.
6. Champoux, J. J. 1993. Roles of ribonuclease H in reverse transcription, p. 103-117. In A. M. Skalka and S. P. Goff (ed.). Reverse transcriptase. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
7. Colicelli, J., and S. P. Goff. 1985. Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell 42:573-580.
8. Colicelli, J., and S. P. Goff. 1988. Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 199:47-59.
9. Donahue, P. R., E. A. Hoover, G. A. Beltz, N. Riedel, V. M. Hirsch, J. Overbaugh, and J. I. Mullins. 1988. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:722-731.
10. Fedoroff, O. Y., Y. Ge, and B. R. Reid. 1997. Solution structure of r(gagg acug):d(CAGTCCTC) hybrid: implications for the initiation of HIV-2 (+)-strand synthesis. J. Mol. Biol. 269:225-239.
11. Fedoroff, O. Y., M. Salazar, and B. R. Reid. 1993. Structure of a DNA:RNA hybrid duplex. Why RNase H does not cleave pure RNA. J. Mol. Biol. 233: 509-523.
12. Gao, H.-Q., P. L. Boyer, E. Arnold, and S. H. Hughes. 1998. Effects of mutations in the polymerase domain on the polymerase. RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase. J. Mol. Biol. 277:559-572.
13. Gelinas, C., and H. M. Temin. 1986. Nondefective spleen necrosis-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl. Acad. Sci. USA 83:9211-9215.
14. Ghosh, M., J. Williams, M. D. Powell, J. G. Levin, and S. F. J. LeGrice. 1997. Mutating a conserved motif of the HIV-1 reverse transcriptase palm subdomain alters primer utilization. Biochemistry 36:5758-5768.
15. Goff, S. P., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
16. Hirsch, V., N. Riedel, and J. I. Mullins. 1987. The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. Cell 49:307-319.
17. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
18. Hodgson, C. P., R. Z. Fisk, P. Arora, and M. Chotani. 1990. Nucleotide sequence of mouse virus-like (VL30) retrotransposon BVL-1. Nucleic Acids Res. 18:673.
19. Howe, C. C., and G. C. Overton. 1986. Expression of the intracistemal A-particle is elevated during differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 6:150-157.
20. Hughes, S. H., Z. Hostomsky, S. F. J. Le Grice, K. Lentz, and E. Arnold. 1996. What is the orientation of DNA polymerases on their templates? J. Virol. 70:2679-2683.
21. Ilyinskii, P. O., and R. C. Desrosiers. 1998. Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus. EMBO J. 17:3766-3774.
22. Kulpa, D., R. Topping, and A. Telesnitsky. 1997. Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors. EMBO J. 16:856-865.
23. Lobel, L. I., M. Patel, W. King, M. C. Nguyen-Huu, and S. P. Goff. 1985. Construction and recovery of viable retroviral genomes carrying a bacterial suppressor transfer RNA gene. Science 228:329-332.
24. Loya, S., H.-Q. Gao, O. Avidan, P. L. Boyer, S. H. Hughes, and A. Hizi. 1997. Subunit-specific mutagenesis of the cysteine 280 residue of the reverse transcriptase of human immunodeficiency virus type 1: effects on sensitivity to a specific inhibitor of the RNase H activity. J. Virol. 71:5668-5672.
25. Luo, G., L. Sharmeen, and J. Taylor. 1990. Specificities involved in the initiation of retroviral plus-strand DNA. J. Virol. 64:592-597.
26. Majors, J. E., and H. E. Varmus. 1983. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene. J. Virol. 47:495-504.
27. Murphy, J. E., and S. P. Goff. 1992. A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J. Virol. 66:5092-5095.
28. Ogert, R. A., L. H. Lee, and K. L. Beemon. 1996. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70:3834-3843.
29. Pear, W. S., M. L. Scott, and G. P. Nolan. 1996. Generation of high titer, helper-free retroviruses by transient transfection, p. 41-57. In P. Robbins (ed.), Methods in molecular medicine: gene therapy protocols. Humana Press, Totowa. N.J.
30. Powell, M. D., M. Ghosh, P. S. Jacques, K. J. Howard, S. F. J. LeGrice, and J. G. Levin. 1997. Alanine-scanning mutations in the "primer grip" of p66 HIV-1 reverse transcriptase result in selective loss of RNA priming activity. J. Biol. Chem. 272:13262-13269.
31. Powell, M. D., and J. G. Levin. 1996. Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immuno-deficiency virus type 1 polypurinc tract. J. Virol. 70:5288-5296.
32. Power, M. D., P. A. Marx, M. L. Bryant, M. B. Gardner, P. J. Barr, and P. A. Luciw. 1986. Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus. Science 231:1567-1572.
33. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway, Jr., M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277-284.
34. Rattray, A. J., and J. J. Champoux. 1989. Plus-strand priming by Moloney murine leukemia virus: the sequence features important for cleavage by RNase H. J. Mol. Biol. 208:445-156.
35. Rattray, A. J., and J. J. Champoux. 1987. The role of Moloney murine leukemia virus RNase H activity in the formation of plus-strand primers. J. Virol. 61:2843-2851.
36. Rausch, J. W., and S. F. J. Le Grice. 1997. Substituting a conserved residue of the ribonuclease H domain alters substrate hydrolysis by retroviral reverse transcriptase. J. Biol. Chem. 272:8602-8610.
37. Saltarelli, M., G. Querat, D. A. Konings, R. Vigne, and J. E. Clements. 1990. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 179:347-364.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
39. Schultz, S. J., and J. J. Champoux. 1996. RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity. J. Virol. 70:8630-8638.
40. Schwartz, D. E., R. Tizard, and W. Gilbert. 1983. Nucleotide sequence of Rous sarcoma virus. Cell 32:853-869.
41. Schwartzberg, P., J. Colicelli, and S. Goff. 1985. Recombination between a defective retrovirus and homologous sequences in host DNA: reversion by patch repair. J. Virol. 53:719-726.
42. Seiki, M., S. Hattori, Y. Hirayama, and M. Yoshida. 1983. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80:3618-3622.
43. Shimotohno, K., S. Mizutani, and H. M. Temin. 1980. Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature 285:550-554.
44. Shinnick, T. M., R. A. Lerner, and J. G. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukaemia virus. Nature 293:543-548.
45. Sonigo, P., C. Barker, E. Hunter, and S. Wain-Hobson. 1986. Nucleotide sequence of Mason-Pfizer monkev virus: an immunosuppressive D-type retrovirus. Cell 45:375-385.
46. Sorge, J., and S. H. Hughes. 1982. Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function. J. Virol. 43: 482-488.
47. Stoye, J. P., and J. M. Coffin. 1987. The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J. Virol. 61:2659-2669.
48. Stoye, J. P., S. Fenner, G. E. Greenoak, C. Moran, and J. M. Coffin. 1988 Role of endogenous retroviruses as mutagens: the hairless mutation of mice. Cell 54:383-391.
49. Stuhlmann, H., R. Janisch, and R. C. Mulligan. 1989. Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol. Cell. Biol. 9:100-108.
50. Tanese, N., and S. P. Goff. 1988. Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc. Natl. Acad. Sci. USA 85:1777-1781.
51. Telesnitsky, A. Unpublished data.
52. Telesnitsky, A., S. Blain, and S. P. Goff. 1995. Assays for retroviral reverse transcriptase. Methods Enzymol. 262:347-362.
53. Tybulewicz, V. L., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153-1163.
54. Wohrl, B. M., M. M. Georgiadis, A. Telesnitsky, W. A. Hendrickson, and S. F. J. LeGrice. 1995. Footprint analysis of replicating murine leukemia virus reverse transcriptase. Science 267:96-99.
55. Zolotukhin, A. S., A. Valentin, G. N. Pavlakis, and B. K. Felber. 1994. Continuous propagation of RRE(-) and Rev(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68:7944-7952.